Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estramustine, Etoposide, Paclitaxel and Hormone Therapy in High-Risk Metastatic Prostate Cancer
NCT00028769Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Dec 2001
- Primary completion
- Jun 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of estramustine, etoposide, paclitaxel in prostate cancer (PCa), sponsored by SWOG Cancer Research Network. Started Dec 2001; status: completed.
02
Drugs
estramustineetoposidepaclitaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00028769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028769.